Study of antiemetic therapy for chemotherapy-induced nausea and vomiting in patients with hematologic malignancy receiving highly emetogenic chemotherapy. - Study of antiemetic therapy for chemotherapy-induced nausea and vomiting in patients with hematologic malignancy receiving highly emetogenic chemotherapy.

Department of Hematology and Oncology, Kurume University Hospital0 个研究点目标入组 40 人开始时间: 2011年9月21日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1) Patient has a serious hepatic insufficiency or renal failure 2) Patient has nausea or vomiting within 24 hours prior to chemotherapy 3) Patient has been treated with antiemetic agents within 24 hours prior to chemotherapy 4) Patient has any illness (e.g. central nervous system tumors, gastrointestinal obstruction, active peptic ulcer, brain metastasis) caused nausea or vomiting except for chemotherapy-induced nausea and vomiting 5) Patient is pregnant or lactating woman, and woman who plans to become pregnant 6) Patient is currently treated with pimozide 7) Patient is judged inappropriate by the investigator as subject for this study

发起方

Department of Hematology and Oncology, Kurume University Hospital